Newsroom

ICU Care Transformed: Precision Medicine Reaches Sepsis and Critical Illness

Consensus Precision Medicine Framework for Sepsis Subtyping Builds on Hector Wong’s Legacy

Immune Cell ‘Signatures’ May Pave the Way for Personalized Treatment in Critically Ill Patients

Immune Signatures Linked to Treatment Response, Outcomes in Critical Illness

Immune cell ‘signatures’ could help guide treatment for critically ill patients

AI-Powered Sepsis Test Shows Promise in Large Clinical Study

All-in-one test could fast-track care for people with possible sepsis

Inflammatix Sepsis Test Outperformed Established Biomarkers, Study Finds

Immune cell ‘signatures’ could help guide treatment for critically ill patients

TriVerity Test Demonstrates High Accuracy in Differentiating Bacterial Versus Viral Infections

FDA clears acute infection and sepsis test

Recognizing It Early While Getting It Right: The Value of Novel Sepsis Testing Tools

A better, faster sepsis test that can save lives

Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps for US Launch

Inflammatix Scores FDA Approval for Precision Infection Test

Inflammatix begins trial evaluating mRNA test for patient infection status

Inflammatix Adds MedTech Veteran as First General Counsel

Inflammatix Raises $57M in Series E Financing

Inflammatix collects $57M as it awaits FDA review of infectious disease test

Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million

Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up

Inflammatix sepsis test scores FDA breakthrough device designation

Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test

Your medical devices are getting smarter. Can the FDA keep them safe?